Medical care of patients with polymyalgia rheumatica: evaluation of guideline-based care and treatment using claims data

• Conditions: M35.3; M31.5; Polymyalgia rheumatica; Giant cell arteritis with polymyalgia rheumatica

• Registration Number: DRKS00028043
• Lead Sponsor: AOK Baden-Württemberg

Brief Summary

Not available

Detailed Description

Not available

Study Timeline

• Study Start: 2022-07-18
• Study Completion: 2023-05-23
• Last Update Posted: 19 August 2024

Recruitment & Eligibility

• Status: Complete
• Sex: All
• Target Recruitment: 27079

Inclusion Criteria

Persons insured with the AOK Baden-Württemberg (regional health insurance fund), incident diagnosis of polymyalgia rheumatica between 2011 and 2020, age =40 years

Exclusion Criteria

Age <40 years; persons, who were not continously insured with the AOK Baden-Württemberg in the two years prior to the incident polymyalgia rheumatica diagnosis.

Study & Design

• Study Type: observational
• Study Design: Not specified

Primary Outcome Measures

Name	Time	Method
Adherance to recommendations of the S3-guideline on treatment of polymyalgia rheumatica

Secondary Outcome Measures

Name	Time	Method
Sex-specific differences in terms of guidelines adherence (S3-guildeline on treatment of polymyalgia rheumatica)